Artificial Limbs and Joints Market is segmented By Product Type (Artificial Joints, Artificial Limbs), By Application Type (Artificial Knee, Artificial Hip, Artificial Elbow, Artificial Shoulder, Artificial Arm, Artificial Leg), By End User (Hospitals, ASCs, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Artificial Limbs and Joints Market Overview
The global artificial limbs and joints market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.7% during the forecast period (2023-2030).
Artificial limbs, or prostheses, substitute a missing body part lost due to trauma or congenital deficiency. The type of prosthesis a person can use depends on the individual, including the reason for limb loss or amputation and the location of the missing extremity.
Artificial Limbs and Joints Market - Strategic Insights
|
Metrics |
Details |
|
Market CAGR |
5.7% |
|
Segments Covered |
By Product Type, By Application Type, By End User and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To know more insights into Market, Get Our Sample Brochure
Artificial Limbs and Joints Market Dynamics
The global artificial limbs and the joint market is driven by technological advancements, the growing adoption of artificial limbs and joints, improving patient awareness, and rising expenditure on cosmetic procedures.
The increasing population of limb-deficient individuals drives the market growth
The rising demand for artificial limbs and joints due to increasing patient awareness drives the market in the forecast period. The complexity of the human extremity, particularly the upper extremity and the hand, allows us to interact with the world. Recent advances in prosthesis technology, surgical innovations, and enhanced rehabilitation appear promising for patients with limb loss who hope to return to their pre-injury level of function.
As per the article published in Prosthesis in 2022, There are over 40 million limb-deficient individuals worldwide, most of whom do not have access to any form of prosthetic care. The World Health Organization has estimated that upper-limb (UL) loss or absence accounts for about 16% of this population. Global estimates for genetic UL differences vary widely and range from 4 to 5/10,000 to 1/100 live births. Acquired UL amputations can be due to a wide variety of aetiologies, with the primary cause often being trauma.
In addition, the reported benefits of body-powered (BP) prostheses include silent action, increased reliability, reduced training period, simple maintenance, lightweight, moderate cost, proprioceptive feedback, and a simple operational mechanism that uses the body motions of the user to voluntary open or close the terminal device. Also, a voluntary closing BP prosthesis offers the user extended physiological proprioception. It extends the proprioceptive feedback to tools that users might engage with.
The issues associated with artificial limbs and joints will hamper the growth of the market
However, most UL prosthetics available to patients are often neither affordable nor applicable in more challenging environments. The issue of appropriate prosthetics is even more pressing for children and adolescents, as fewer options are available. These factors are hampering the market growth.
COVID-19 Impact Analysis on Artificial Limbs and Joints Market
The appearance of COVID-19 considerably impacted the global artificial limbs and joints market. As per the article published in The Journal of Arthroplasty in 2020, the COVID-19 pandemic has resulted in exceptional restrictions to curb the pandemic’s impact, impacting all aspects of society. The healthcare industry has been particularly affected. The ACS, the CMS, and most states have advised or required that only essential surgical procedures be performed during the COVID-19 outbreak.
However, this mandated reduction of unnecessary surgical procedures will profoundly impact the healthcare system. Furthermore, given that hip and knee arthroplasty comprise a substantial share of the surgical volume in the U.S., there is no doubt these policies are hard felt by hip and knee arthroplasty patients and the providers and institutions that care for them.
However, a predicted surge of rescheduling canceled cases is based on the assumption that patients will want to reschedule their surgery or new patients will want to be indicated for surgery, as the situation is recovering from COVID-19—results in the increasing demand for artificial limbs and joints worldwide.
Artificial Limbs and Joints Market Segment Analysis
The artificial knee segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The artificial knee segment accounts for the largest market share. As per the article published in the Journal of clinical medicine 2021, total knee arthroplasty (TKA) is a very effective treatment for severe osteoarthritis. TKA leads to good results in returning to daily activities, good survival rates, and overall functional improvement. Technologies such as navigation, smart tools, patient-specific instrumentation (PSI), and computer or robotic-assisted surgery (CAS) aim to individualize the surgery and account for the anatomy and ligament balancing of each patient to improve the accuracy of the surgical planning in three dimensions (3D), to increase alignment accuracy and reliability, and improve implant positioning.
In addition, the key players are adopting market strategies such as product launches and collaboration to expand their business. For instance, in April 2022, Researchers at the Indian Institute of Technology-Madras (IIT-M) introduced India's first polycentric prosthetic knee. Named 'Kadam,' the indigenously designed prosthetic knee aims to enhance the quality of life of above-knee amputees.
Artificial Limbs and Joints Market Geographical Analysis
North America region holds the largest market share of the global artificial limbs and joints market
North America dominates the artificial limbs and joints market and is anticipated to show a parallel trend over the forecast period. The market is boosted by factors such as advanced healthcare infrastructure, the increasing incidence of injuries and accidents, active regional key players, and growing awareness about advanced prosthetic technologies in the North American region.
As per the article published in Current Reviews in Musculoskeletal Medicine in 2020, an estimated 1.6 million Americans were living with limb loss in 2005, with a projected increase to 3.6 million by 2050. Upper extremity limb loss accounts for approximately one-third of that group, though major amputations (those proximal to the digits) represent only 8% of upper extremity amputations. Trauma is the second main cause of amputation, occurring at approximately one-eighth of the amputation rate secondary to vascular disease.
As per the article published in Techniques in Orthopaedics in December 2021, presently, 2.1 million people in the U.S. live with limb loss, with 185,000 amputations happening each year. Amputation numbers are predicted to rise with increasing age, diabetes, and vascular disease in the population. Advances in surgical techniques and prosthetic technology have created the potential for amputees to live active and productive lives.
Artificial Limbs and Joints Companies & Competitive Landscape
The artificial limbs and joints market is a moderately competitive presence of local and global companies. Some key players contributing to the market's growth are Arthrex Inc, Depuy Synthes (Johnson & Johnson) (Johnson & Johnson), Djo Surgical, Integra Lifesciences, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Holdings Inc., Ă–ssur, and Conmed Corporation, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the artificial limbs and joints market globally.
For instance,
- In September 2021, the Cleveland Clinic-led international research team developed the bionic system that combines three important functions – intuitive motor control, touch and grip kinesthesia, and the intuitive feeling of opening and closing the hand. Collaborators included the University of Alberta and the University of New Brunswick.
Allergan plc
Overview:
Stryker Corporation is a medical device company founded in 1941 and headquartered in the United States. The company offers innovative products and services in neurotechnology, medical and surgical, orthopaedics and spine that help enhance patient and hospital outcomes.
Product Portfolio:
Accolade II: The company created Accolade II’s Morphometric Wedge to manage modern demands with novel technology by developing a conventional tapered wedge femoral stem design with size-specific medial curvature to more closely fit an expansive range of bone sizes and shapes of today’s patient population.
The global artificial limbs and joints market report would provide access to approximately 65+ market data tables, 60+ figures, and in the range of 200+ (approximate) pages.
